Ki67, e-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors

Transplantation

Volumn 73, Issue 3, 2002, Pages 386-394

  Rosenau, Jens ^a   Bahr, Matthias J ^a   Von Wasielewski, Reinhard ^a   Mengel, Michael ^a   Schmidt, Hartmut H J ^a   Nashan, Björn ^a   Lang, Hauke ^a   Klempnauer, Jürgen ^a   Manns, Michael P ^a   Boeker, Klaus H W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; UVOMORULIN;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0037084205     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202150-00012     Document Type: Article

References (29)

1. An analysis of 8305 cases of carcinoid tumors
2. Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients
3. Assessment of five-year experience with abdominal organ cluster transplantation
4. The Ki-67 protein: From the known and the unknown
5. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy
6. E-cadherin as tumor differentiation marker and as architectural determinant
7. E-cadherin mediated adhesion system in cancer cells
8. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome
9. p53 tumor-suppressor gene: Clues to molecular carcinogenesis
10. Clinical implications of p53: Effect on prognosis, tumor progression and chemotherapy response
11. Liver transplantation for metastatic neuroendocrine tumors
12. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas: A single center experience with ten patients
13. Tyramine amplification technique in routine pathology
14. Proceed with caution: Liver transplantation for metastatic neuroendocrine tumors
15. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors
16. An odyssey in the land of small tumors
17. Prognostic variables in patients with gastrointestinal carcinoid tumours
18. Gastrointestinal carcinoid tumors and the malignant carcinoid syndrome
19. The management of patients with advanced carcinoid tumors and islet cell carcinomas
20. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors
21. Treatment of liver metastases of carcinoid tumors
22. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors
23. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours
24. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors
25. Hepatic resection for metastatic neuroendocrine carcinomas
26. Cytoreductive hepatic surgery for neuroendocrine tumors
27. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: A 31-case French multicentric report
28. Upper abdominal exenteration and orthotopic liver transplantation: A concept of surgical treatment for regional metastasizing tumors of the endocrine pancreas
29. Results of liver transplantation for gastroenteropancreatic tumor metastases